Overcoming barriers by local drug delivery with liposomes

被引:201
|
作者
Antimisiaris, S. G. [1 ,2 ]
Marazioti, A. [1 ]
Kannavou, M. [1 ,2 ]
Natsaridis, E. [1 ,2 ]
Gkartziou, F. [2 ]
Kogkos, G. [1 ,2 ]
Mourtas, S. [1 ]
机构
[1] Univ Patras, Sch Hlth Sci, Dept Pharm, Lab Pharmaceut Technol, Rion 26504, Greece
[2] Fdn Res & Technol Hellas FORTH ICES, Inst Chem Engn Sci, Rion 26504, Greece
关键词
Liposomes; Drug; Topical routes; Local delivery; Administration; Ocular; Pulmonary; Nasal; Oral; Intratumoral; Vaginal; Vaccine; COVID-19; BLOOD-BRAIN-BARRIER; SURFACE-MODIFIED LIPOSOMES; IN-VITRO CHARACTERIZATION; SUSTAINED-RELEASE; TRANSDERMAL DELIVERY; CATIONIC LIPOSOMES; LOADED LIPOSOMES; OCULAR DELIVERY; DRY POWDER; BIOLOGICAL BARRIERS;
D O I
10.1016/j.addr.2021.01.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Localized or topical administration of drugs may be considered as a potential approach for overcoming the problems caused by the various biological barriers encountered in drug delivery. The combination of using localized administration routes and delivering drugs in nanoparticulate formulations, such as liposomes, may have additional advantages. Such advantages include prolonged retention of high drug loads at the site of action and controlled release of the drug, ensuring prolonged therapeutic effect; decreased potential for side-effects and toxicity (due to the high topical concentrations of drugs); and increased protection of drugs from possible harsh environments at the site of action. The use of targeted liposomal formulations may further potentiate any acquired therapeutic advantages. In this review we present the most advanced cases of localized delivery of liposomal formulations of drugs, which have been investigated pre-clinically and clinically in the last ten years, together with the reported therapeutic advantages, in each case. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:53 / 86
页数:34
相关论文
共 50 条
  • [41] LIPOSOMES AS A DRUG DELIVERY SYSTEM
    WEINER, N
    MARTIN, F
    RIAZ, M
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (10) : 1523 - 1554
  • [42] Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective
    Hemrajani, Chetna
    Negi, Poonam
    Parashar, Arun
    Gupta, Gaurav
    Jha, Niraj Kumar
    Singh, Sachin Kumar
    Chellappan, Dinesh Kumar
    Dua, Kamal
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [43] LIPOSOMES AS DRUG DELIVERY SYSTEMS
    IWAMOTO, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 17 - POLY
  • [44] Temperature sensitive liposomes for local drug delivery using focused ultrasound.
    Larabi, Malika
    Mackanos, Mark
    Shinde, Rajesh
    Contag, Chris
    Guccione, Samira
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3561S - 3561S
  • [45] Hydroxyapatite-coated liposomes for potential use as local drug delivery devices
    Xu, Qingguo
    Czernuszka, Jan
    TISSUE ENGINEERING, 2007, 13 (06): : 1382 - 1382
  • [46] Overcoming barriers: Challenges and opportunities in macromolecular delivery
    Alpar, HO
    TOXICOLOGY, 2006, 219 (1-3) : 236 - 237
  • [47] Overcoming barriers to nonviral gene delivery.
    Behr, JP
    BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (01) : 58 - 60
  • [48] Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
    Liu, Jing
    Cabral, Horacio
    Mi, Peng
    ADVANCED DRUG DELIVERY REVIEWS, 2024, 207
  • [50] Vascular oncoproteomics for tissue-specific targeting and overcoming barriers to drug and gene delivery in vivo
    Jan Schnitzer
    Nature Genetics, 2001, 27 (Suppl 4) : 85 - 85